OMTHERA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Omthe...
28 Maio 2013 - 10:00PM
Business Wire
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
and the law firm of Kahn Swick & Foti, LLC (“KSF”) announce
that KSF has commenced an investigation into the Board of Directors
of Omthera Pharmaceuticals, Inc. (“Omthera” or the “Company)
(NASDAQ GM: OMTH) in connection with their conduct related to the
sale of the Company to AstraZeneca. Under the terms of the proposed
transaction, shareholders of Omthera will receive $12.70 in cash
for each share of Omthera common stock that they own. In addition,
each Omthera shareholder will receive Contingent Value Rights of up
to approximately $4.70 per share if specified milestones are
achieved.
KSF’s investigation is focusing on whether Omthera and/or its
officers and directors secured sufficient value for the
shareholders of the Company, violated their fiduciary duties,
and/or violated state or federal securities laws.
If you have information that would assist KSF in its
investigation, or would like to discuss your legal rights, you may,
without obligation or cost to you, e-mail or call KSF Managing
Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) or attorney
Michael Palestina (michael.palestina@ksfcounsel.com) toll free at
855-768-1857 or via cell phone any time at 504-236-7315.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney
General Charles C. Foti, Jr., is a law firm focused on
transactional litigation, as well as securities class action and
shareholder derivative litigation. With offices in New York and
Louisiana, KSF's lawyers have significant experience litigating
complex securities class actions nationwide on behalf of both
institutional and individual shareholders.
To learn more about KSF, you may visit www.ksfcounsel.com.
OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Omthera Pharmaceuticals, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Omthera Pharmaceuticals, Inc. (MM)